Literature DB >> 25709930

Clinical correlates of common corneal neovascular diseases: a literature review.

Nizar Saleh Abdelfattah1, Mohamed Amgad2, Amira A Zayed3, Hamdy Salem4, Ahmed E Elkhanany5, Heba Hussein6, Nawal Abd El-Baky7.   

Abstract

A large subset of corneal pathologies involves the formation of new blood and lymph vessels (neovascularization), leading to compromised visual acuity. This article aims to review the clinical causes and presentations of corneal neovascularization (CNV) by examining the mechanisms behind common CNV-related corneal pathologies, with a particular focus on herpes simplex stromal keratitis, contact lenses-induced keratitis and CNV secondary to keratoplasty. Moreover, we reviewed CNV in the context of different types of corneal transplantation and keratoprosthesis, and summarized the most relevant treatments available so far.

Entities:  

Keywords:  contact lens; cornea; herpes simplex keratitis; keratoplasty; keratoprosthesis; neovascularization

Year:  2015        PMID： 25709930      PMCID： PMC4325264          DOI： 10.3980/j.issn.2222-3959.2015.01.32

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


  140 in total

1.  Immunohistochemistry of Terrien's and Mooren's corneal degeneration.

Authors:  J S Lopez; F W Price; S M Whitcup; Q Li; M de Smet; C C Chan
Journal:  Arch Ophthalmol       Date:  1991-07

2.  Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A.

Authors:  U Benelli; J R Ross; M Nardi; G K Klintworth
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-02       Impact factor: 4.799

3.  Angiogenesis in corneal diseases: histopathologic evaluation of 254 human corneal buttons with neovascularization.

Authors:  C Cursiefen; M Küchle; G O Naumann
Journal:  Cornea       Date:  1998-11       Impact factor: 2.651

4.  Phosphorothioate oligodeoxynucleotides inhibit basic fibroblast growth factor-induced angiogenesis in vitro and in vivo.

Authors:  I Kitajima; K Unoki; I Maruyama
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1999-04

5.  Rapid ocular angiogenic control via naked DNA delivery to cornea.

Authors:  S U Stechschulte; A M Joussen; H A von Recum; V Poulaki; Y Moromizato; J Yuan; R J D'Amato; C Kuo; A P Adamis
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-08       Impact factor: 4.799

6.  Long-term follow-up of patients with atopic keratoconjunctivitis.

Authors:  W J Power; I Tugal-Tutkun; C S Foster
Journal:  Ophthalmology       Date:  1998-04       Impact factor: 12.079

7.  Control of stromal keratitis by inhibition of neovascularization.

Authors:  M Zheng; M A Schwarz; S Lee; U Kumaraguru; B T Rouse
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

8.  Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.

Authors:  Efdal Yoeruek; Focke Ziemssen; Sigrid Henke-Fahle; Olcay Tatar; Aysegül Tura; Salvatore Grisanti; Karl U Bartz-Schmidt; Peter Szurman
Journal:  Acta Ophthalmol       Date:  2007-11-08       Impact factor: 3.761

9.  Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results.

Authors:  Jonathan H Lass; Robin L Gal; Mariya Dontchev; Roy W Beck; Craig Kollman; Steven P Dunn; Ellen Heck; Edward J Holland; Mark J Mannis; Monty M Montoya; Robert L Schultze; R Doyle Stulting; Alan Sugar; Joel Sugar; Bradley Tennant; David D Verdier
Journal:  Ophthalmology       Date:  2008-04       Impact factor: 12.079

10.  Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

Authors:  Jeffrey S Heier; David M Brown; Victor Chong; Jean-Francois Korobelnik; Peter K Kaiser; Quan Dong Nguyen; Bernd Kirchhof; Allen Ho; Yuichiro Ogura; George D Yancopoulos; Neil Stahl; Robert Vitti; Alyson J Berliner; Yuhwen Soo; Majid Anderesi; Georg Groetzbach; Bernd Sommerauer; Rupert Sandbrink; Christian Simader; Ursula Schmidt-Erfurth
Journal:  Ophthalmology       Date:  2012-10-17       Impact factor: 12.079
View more
  26 in total

Review 1.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

Review 2.  Host immune cellular reactions in corneal neovascularization.

Authors:  Nizar S Abdelfattah; Mohamed Amgad; Amira A Zayed
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

3.  Knockdown of CXCL14 disrupts neurovascular patterning during ocular development.

Authors:  Ana F Ojeda; Ravi P Munjaal; Peter Y Lwigale
Journal:  Dev Biol       Date:  2017-01-15       Impact factor: 3.582

Review 4.  Contact Lens-induced Limbal Stem Cell Deficiency.

Authors:  Jennifer Rossen; Alec Amram; Behrad Milani; Dongwook Park; Jennifer Harthan; Charlotte Joslin; Timothy McMahon; Ali Djalilian
Journal:  Ocul Surf       Date:  2016-07-30       Impact factor: 5.033

Review 5.  LncRNAs in ocular neovascularizations.

Authors:  Yacouba Cissé; Lang Bai; Min-Ting Chen
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

6.  Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway.

Authors:  M García-Caballero; S Blacher; J Paupert; A R Quesada; M A Medina; A Noël
Journal:  Br J Pharmacol       Date:  2016-05-04       Impact factor: 8.739

7.  Function-first ligandomics for ocular vascular research and drug target discovery.

Authors:  Xin Rong; Hong Tian; Liu Yang; Wei Li
Journal:  Exp Eye Res       Date:  2019-03-21       Impact factor: 3.467

Review 8.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

9.  In vivo photoacoustic imaging for monitoring treatment outcome of corneal neovascularization with metformin eye drops.

Authors:  Kwok-Ho Lui; Shiying Li; Wai-Sum Lo; Yanjuan Gu; Wing-Tak Wong
Journal:  Biomed Opt Express       Date:  2021-05-21       Impact factor: 3.732

10.  Comparison of the inhibitory effect of different doses of subconjunctival bevacizumab application in an experimental model of corneal neovascularization.

Authors:  Burak Ulas; Rana Altan-Yaycioglu; Nebil Bal
Journal:  Int J Ophthalmol       Date:  2018-07-18       Impact factor: 1.779
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.